HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant Hemangiopericytoma

A malignant endothelial neoplasm (hemangiopericytoma) that originates from adventitial perivascular cells or PERICYTES. OMIM: 234820
Also Known As:
Hemangiopericytoma, Malignant
Networked: 24 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Malignant Fibrous Histiocytoma
4. Disease Progression
5. Angiofibroma

Experts

1. Chipczyńska, Barbara: 1 article (01/2012)
2. Grałek, Mirosława: 1 article (01/2012)
3. Benesch, M: 1 article (04/2008)
4. Bode, U: 1 article (04/2008)
5. Fleischhack, G: 1 article (04/2008)
6. Gadner, H: 1 article (04/2008)
7. Lackner, H: 1 article (04/2008)
8. Sauseng, W: 1 article (04/2008)
9. Urban, C: 1 article (04/2008)
10. Windelberg, M: 1 article (04/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Malignant Hemangiopericytoma:
1. Doxorubicin (Adriamycin)FDA LinkGeneric
2. IfosfamideFDA LinkGeneric
3. Dacarbazine (DIC)FDA LinkGeneric
4. Interferon-alpha (Interferon Alfa)IBA
5. VimentinIBA
6. Messenger RNA (mRNA)IBA
7. Methotrexate (Mexate)FDA LinkGeneric
8. IceIBA
9. Hypoglycemic Agents (Hypoglycemics)IBA
10. EnzymesIBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Radiotherapy
3. Combination Drug Therapy (Combination Chemotherapy)
4. Therapeutics
5. Laparotomy